Interestingly, previous studies have shown that APOE4 is associated with an increased risk of cardiovascular diseases [42], poorer outcomes after disease or injury in the peripheral nervous system [43], as well as the frequency and severity of diabetic neuropathy [44,45] in patients with diabetes. Here, APOE is linked to diabetic neuropathy.